Common Use:

Xifaxan is a unique and versatile non-absorbable gut antibiotic containing rifaximin, a semisynthetic rifamycin derivative that works almost exclusively within the gastrointestinal tract with minimal systemic absorption — less than 0.4% of the oral dose reaches the bloodstream under normal circumstances. This remarkable pharmacokinetic property allows rifaximin to deliver powerful antibacterial action directly where it is needed while sparing the rest of the body from the side effects commonly associated with systemic antibiotics. When you buy Xifaxan online, you receive an effective and well-tolerated Xifaxan generic for treating a range of gastrointestinal and bowel disorders that significantly impact patients' quality of life. This gut antibiotic has three primary FDA-approved indications: treating traveler's diarrhea caused by non-invasive strains of Escherichia coli (the most common cause of infectious diarrhea in international travelers), reducing the recurrence of overt hepatic encephalopathy in patients with advanced chronic liver disease and cirrhosis, and providing effective IBS-D treatment (irritable bowel syndrome with predominant diarrhea) — a chronic functional bowel disorder affecting millions worldwide. Rifaximin works by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase, thereby inhibiting bacterial RNA synthesis and effectively reducing pathogenic and gas-producing bacterial populations in the gut lumen. Importantly, because this non-absorbable antibiotic acts primarily within the intestinal lumen and has a unique mechanism of action, it offers the significant advantage of targeted treatment with substantially fewer systemic side effects compared to conventional oral antibiotics, minimal disruption of the beneficial normal intestinal microbiome, and a very low risk of promoting widespread antibiotic resistance. For patients seeking to buy rifaximin for gut-related conditions, Xifaxan represents a gold standard in localized gastrointestinal antibiotic therapy.

Dosage and Direction:

Take Xifaxan exactly as prescribed by your healthcare provider, as the dosage varies significantly depending on the specific condition being treated. For traveler's diarrhea, the typical dose is 200 mg taken orally three times daily (every 8 hours) for 3 consecutive days; treatment should be discontinued if diarrhea worsens or persists beyond 24–48 hours, as this may indicate an invasive organism not susceptible to rifaximin. For IBS-D treatment, the recommended dose is 550 mg taken three times daily for a 14-day treatment course, with retreatment with another 14-day course possible if symptoms recur — studies have shown that up to 3 repeated courses may be effective. For reduction and prevention of hepatic encephalopathy recurrence in patients with chronic liver disease, the standard dose is 550 mg taken twice daily on an ongoing, long-term basis, often in combination with lactulose. This Xifaxan generic can be taken with or without food, as bioavailability is not significantly affected by meals, and tablets should be swallowed whole with a full glass of water. Do not crush, break, chew, or dissolve the tablets, as this may alter the drug's release characteristics. Treatment duration and dosing should never be altered without explicit medical advice from your healthcare provider. When you buy rifaximin, always adhere strictly to the prescribed regimen for optimal outcomes in managing your specific bowel disorder, and complete the full course of treatment even if symptoms improve before the course is finished.

Precautions:

Before starting Xifaxan, inform your doctor about all existing medical conditions, particularly liver problems. Patients with severe hepatic impairment (Child-Pugh Class C) require special consideration, as rifaximin systemic exposure may be significantly increased — by up to 10 to 20-fold — in patients with advanced decompensated liver disease, potentially increasing the risk of systemic adverse effects. Report any known allergies to rifamycin-class antibiotics, including rifampin, rifabutin, or rifapentine, as immunological cross-sensitivity may occur. While this gut antibiotic is designed and approved for use in specific intestinal conditions, it should absolutely not be used to self-treat diarrhea accompanied by fever above 101°F (38.3°C) or bloody stools, as these symptoms strongly suggest invasive bacterial infection or other serious conditions requiring systemic antibiotic therapy and proper medical evaluation. Long-term, repeated, or inappropriate use of this non-absorbable antibiotic may potentially contribute to bacterial resistance patterns or superinfection with resistant organisms, including Clostridium difficile, although the risk appears to be lower than with systemic antibiotics. If diarrhea worsens, persists beyond the expected treatment duration, or is accompanied by new symptoms such as fever or blood, discontinue use and contact your healthcare provider immediately for further evaluation and alternative treatment. Regular liver function monitoring (ALT, AST, bilirubin) is recommended for patients using rifaximin long-term for hepatic encephalopathy prevention, and any signs of worsening liver function should be reported promptly. Pregnant women should discuss the risks and benefits with their physician before use.

Contraindications:

Xifaxan should not be used by individuals with a known allergy or hypersensitivity to rifaximin, any other rifamycin-class antibiotic (rifampin, rifabutin, rifapentine), or any inactive ingredient in the formulation — allergic reactions can range from mild skin rash to severe anaphylaxis. This gut antibiotic is specifically designed for gastrointestinal conditions and is not appropriate or effective for treating infections outside the digestive tract, systemic bacterial infections, or diarrhea caused by invasive pathogens other than non-invasive E. coli. It should never be used to treat dysentery (diarrhea complicated by high fever and/or blood or mucus in the stool), as patients with invasive enteric infections require prompt systemic antibiotic therapy. Pregnant women should use this non-absorbable antibiotic only if the potential benefits clearly outweigh the risks to the developing fetus, as adequate and well-controlled studies in pregnant women have not been conducted — animal reproduction studies have shown some adverse developmental effects at high doses. Breastfeeding mothers should consult their doctor before initiating rifaximin therapy, as it is currently unknown whether the drug or its metabolites pass into breast milk in clinically significant amounts, although systemic absorption is minimal.

Possible Side Effect:

Common side effects of this Xifaxan generic are generally mild to moderate and include nausea, flatulence (intestinal gas), headache, abdominal bloating and distension, abdominal pain or cramping, and constipation. The specific side effect profile varies somewhat depending on the condition being treated. For patients using rifaximin for IBS-D treatment, commonly reported effects also include peripheral edema (swelling of extremities), dizziness, fatigue, muscle spasms, and arthralgia (joint pain). In patients receiving long-term therapy for hepatic encephalopathy prevention, common side effects include peripheral edema, nausea, dizziness, fatigue, ascites (abdominal fluid accumulation), and occasional worsening of liver function tests. Serious allergic reactions are rare but clinically important — they may manifest as widespread skin rash, hives (urticaria), intense itching (pruritus), swelling of the face, lips, tongue, or throat (angioedema), and difficulty breathing or wheezing, requiring immediate emergency medical attention. In rare cases, Clostridium difficile-associated diarrhea (CDAD) has been reported with the use of nearly all antibacterial agents, including this gut antibiotic — C. difficile infection can range from mild diarrhea to life-threatening pseudomembranous colitis. If you experience persistent watery diarrhea that does not improve, worsening abdominal cramps, blood or mucus in stool, or fever during or after treatment, contact your healthcare provider immediately for evaluation of this potentially serious bowel disorder complication.

Drug Interaction:

While Xifaxan has fewer systemic drug interactions than most antibiotics due to its minimal absorption, several interactions merit clinical attention. Rifaximin is both a substrate and a mild inducer of the CYP3A4 enzyme system and P-glycoprotein (P-gp) transport protein. Concurrent administration with cyclosporine or other potent P-glycoprotein inhibitors may significantly increase rifaximin systemic absorption and plasma levels — in one study, co-administration with cyclosporine increased rifaximin AUC by approximately 83-fold. Warfarin anticoagulant effects (INR) should be monitored during concurrent use with this non-absorbable antibiotic, particularly in patients with hepatic impairment who may have higher systemic drug levels. Rifaximin may potentially reduce the effectiveness of oral contraceptive pills through induction of intestinal CYP3A4, although clinical significance is uncertain — backup contraceptive methods may be considered during treatment as a precaution. Benzodiazepines and other CYP3A4 substrates may theoretically have altered metabolism, though clinical significance with standard rifaximin doses appears limited. In patients with significant hepatic impairment, systemic drug levels of rifaximin can be dramatically elevated, making drug interactions substantially more clinically relevant and requiring enhanced vigilance. Always provide your healthcare provider with a comprehensive and current medication list, including all prescription drugs, over-the-counter products, vitamins, and dietary supplements, to identify and avoid potential adverse interactions when you buy Xifaxan online for traveler's diarrhea, IBS-D treatment, or hepatic encephalopathy management.

Missed Dose:

If you miss a dose of this gut antibiotic, take it as soon as you remember. If it is already close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule — do not take a double dose to compensate for the missed one. Completing the full prescribed course of this non-absorbable antibiotic is critically important for effective treatment of traveler's diarrhea, IBS-D, or hepatic encephalopathy prevention, even if your symptoms improve noticeably before the course is finished. Stopping treatment early may allow pathogenic bacteria to recover and symptoms to return, potentially reducing the overall effectiveness of your bowel disorder therapy. If you miss multiple doses or are unsure how to proceed, contact your healthcare provider for guidance on whether to continue, restart, or modify your treatment plan.

Overdose:

An overdose of Xifaxan (rifaximin) is unlikely to cause life-threatening systemic effects due to its characteristically minimal absorption from the gastrointestinal tract, but it may cause intensified and uncomfortable gastrointestinal side effects such as severe nausea, significant abdominal discomfort and cramping, excessive flatulence, and diarrhea. If a substantial overdose is suspected, seek immediate medical help or contact your local poison control center. Treatment is entirely supportive and symptom-based, focusing on managing gastrointestinal symptoms and ensuring adequate hydration. There is no specific antidote for rifaximin overdose. Medical professionals will monitor symptoms, provide appropriate supportive care, and observe for any unexpected systemic effects, particularly in patients with pre-existing liver disease where absorption may be increased. This bowel disorder medication has a generally wide safety margin due to its limited systemic bioavailability.

Storage:

Store Xifaxan at controlled room temperature between 20–25°C (68–77°F), with brief excursions permitted between 15–30°C (59–86°F). Keep this gut antibiotic in its original container, tightly closed, away from moisture, excessive heat, and direct light. Store securely out of reach of children and pets. Do not store in the bathroom or other humid environments, as moisture can degrade the medication. Do not use this IBS-D treatment, traveler's diarrhea medication, or hepatic encephalopathy prevention therapy after the expiration date printed on the package or bottle label. Dispose of unused or expired non-absorbable antibiotic medication according to local pharmaceutical waste guidelines, or consult your pharmacist for proper and environmentally responsible disposal methods.

Disclaimer
We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.